Revolution Medicines, Inc.

NasdaqGS:RVMD Stock Report

Market Cap: US$6.9b

Revolution Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:RVMD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Sep 23SellUS$78,715Margaret HornIndividual2,514US$31.31
18 Sep 23SellUS$38,011Jeff CisliniIndividual1,214US$31.31
18 Sep 23SellUS$44,680Jack AndersIndividual1,427US$31.31
18 Sep 23SellUS$252,175Mark GoldsmithIndividual8,054US$31.31
18 Sep 23SellUS$64,500Stephen KelseyIndividual2,060US$31.31
20 Jun 23SellUS$31,148Jeff CisliniIndividual1,239US$25.14
20 Jun 23SellUS$31,089Jack AndersIndividual1,249US$24.89
20 Jun 23SellUS$52,321Margaret HornIndividual2,102US$24.89
20 Jun 23SellUS$52,321Stephen KelseyIndividual2,102US$24.89

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RVMD?
Owner TypeNumber of SharesOwnership Percentage
Private Companies8,5720.00503%
Public Companies47,0140.0276%
Individual Insiders3,769,1012.21%
General Public9,310,3305.46%
Institutions157,358,13192.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 60.4%.


Top Shareholders

Top 25 shareholders own 76.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.73%
Wellington Management Group LLP
14,882,086US$598.3m40.8%0.09%
8.58%
The Vanguard Group, Inc.
14,634,391US$588.3m51.8%0.01%
7.6%
BlackRock, Inc.
12,954,314US$520.8m46%0.01%
3.95%
Farallon Capital Management, L.L.C.
6,736,854US$270.8m103%1.81%
3.69%
Nextech Invest Ltd.
6,296,560US$253.1m0%40.62%
3.67%
State Street Global Advisors, Inc.
6,253,361US$251.4m61.7%0.01%
3.51%
BVF Partners L.P.
5,981,212US$240.4m50.2%5.49%
3.35%
Casdin Capital, LLC
5,714,775US$229.7m216%18.09%
3.08%
GV Management Company, LLC
5,254,498US$211.2m0%17.8%
3.02%
Baker Bros. Advisors LP
5,148,657US$207.0m91.3%2.42%
2.99%
Bellevue Asset Management AG
5,091,000US$204.7m7.83%2.21%
2.72%
T. Rowe Price Group, Inc.
4,636,353US$186.4m-9%0.02%
2.51%
Tavistock Life Sciences
4,279,464US$172.0m-8.64%9.44%
2.44%
FMR LLC
4,164,115US$167.4m496%0.01%
2.39%
JP Morgan Asset Management
4,079,419US$164.0m0.64%0.02%
1.9%
Arch Venture Partners, L.P.
3,233,490US$130.0m0%9.06%
1.81%
Deerfield Management Company, L.P. Series C
3,090,073US$124.2m76.4%2.29%
1.75%
Geode Capital Management, LLC
2,978,784US$119.7m43.7%0.01%
1.74%
Woodline Partners LP
2,960,040US$119.0m-5.89%1.26%
1.69%
Holocene Advisors, LP
2,882,155US$115.9m31.6%0.42%
1.36%
Alexis Borisy
2,326,294US$93.5m0%no data
1.29%
Janus Henderson Group plc
2,199,480US$88.4m-1.84%0.04%
1.05%
Dimensional Fund Advisors LP
1,795,421US$72.2m8.04%0.01%
0.99%
Artal Group S.A.
1,695,949US$68.2m-33%1.86%
0.95%
Columbia Management Investment Advisers, LLC
1,623,021US$65.2m33.9%0.02%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.